𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Apoptotic cells induce dendritic cell-mediated suppression via interferon-γ-induced IDO

✍ Scribed by Charlotte A. Williams; Rachel A. Harry; Julie D. McLeod


Book ID
108782231
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
449 KB
Volume
124
Category
Article
ISSN
0019-2805

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Interferon regulatory factor-1 mediates
✍ Eun-Joo Kim; Joon-Mo Lee; Sung-Eun Namkoong; Soo-Jong Um; Jong-Sup Park 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

## Abstract Interferon‐γ (IFN‐γ), as one of interferon family that regulates antiviral, antiproliferative, and immunomodulatory responses, has been implicated for the growth regulation of ovarian cancer cells. However, the molecular mechanisms are not yet fully defined. To analyze detailed mechanis

Suppression by interferon-γ of tumor cel
✍ Akihiko Uchiyama; Hisao Kitsuki; Hideo Shimura; Motomichi Torisu 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 710 KB

The effect of interferon-gamma (IFN-gamma) on the interaction between tumor cells and mesothelial cell layers was studied from the aspect of changes in mesothelial permeability. Mesothelial permeability was assessed as the percentage diffusion of radiolabeled albumin across the mesothelial cell shee

IFN-γinduces cell death in human hepatom
✍ Eui-Cheol Shin; Ju Mi Ahn; Chul Hoon Kim; Youjeong Choi; Young Soo Ahn; Hoguen K 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 281 KB

We demonstrated the induction of cell death in a hepatoma cell line by IFN-gamma and its possible mechanism. Among the 2 hepatitis B virus (HBV)-associated hepatoma cell lines, SNU-354 and SNU-368, IFN-gamma induced cell death and increased caspase-3 activity in SNU-368 but not in SNU-354. IFN-gamma

Modification of dendritic cells with int
✍ Tae Heung Kang; Hyun Cheol Bae; Seok-Ho Kim; Su Hong Seo; Sang Wook Son; Eun You 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB

## Abstract ## Background Dendritic cell (DC)‐based vaccines have become a promising modality in cancer immunotherapy. However, their ability to initiate tumor antigen‐specific T cell immunity is limited in various negative‐feedback mechanisms. The rapid down‐regulation of chemokines, such as the